PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
http://www.peervoice.com
Gesamtlänge aller Episoden: 3 days 21 hours 37 minutes
Transforming Management of Early-Stage EGFR-Mutant NSCLC: Insights From the Latest Data
Transforming Management of Early-Stage EGFR-Mutant NSCLC: Insights From the Latest Data
Defining Control in Moderate-to-Severe Asthma: Where Are We Now and What Can We Do?
Defining Control in Moderate-to-Severe Asthma: Where Are We Now and What Can We Do?
Best Practices for MET Mutation Testing in NSCLC: The Role of the Oncologist and the Pathologist
Best Practices for MET Mutation Testing in NSCLC: The Role of the Oncologist and the Pathologist
New Targets in Heart Failure: Congress Updates on SGLT2 Inhibitors
New Targets in Heart Failure: Congress Updates on SGLT2 Inhibitors
Halting the Cascade of Chronic Kidney Disease: Can We Catch Patients Before They Fall?
Halting the Cascade of Chronic Kidney Disease: Can We Catch Patients Before They Fall?
A Look at Emerging SMA Outcomes: Highlights of CureSMA 2020
A Look at Emerging SMA Outcomes: Highlights of CureSMA 2020
A Look at Emerging SMA Outcomes: Highlights of EAN 2020
A Look at Emerging SMA Outcomes: Highlights of EAN 2020
Deciphering the Role of MET Alterations in Advanced NSCLC: Unmet Needs
Deciphering the Role of MET Alterations in Advanced NSCLC: Unmet Needs
Keeping the Pace With Immunotherapy for First-Line NSCLC Treatment: Translating the Latest Evidence to Practice
Visit https://www.peervoice.com/NZH860 to view the entire programme with slides.
New Targets, New Hope in SMA: A 2020 Congress Coverage
New Targets, New Hope in SMA: A 2020 Congress Coverage